Robert Yang

Title: The Innovative Contributions of Robert Yang

Introduction

Robert Yang is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of receptor tyrosine kinases. His work focuses on developing methods to identify inhibitors that can potentially lead to advancements in cancer treatment.

Latest Patents

Robert Yang holds a patent for "Inhibitors of Tyrosine Kinase Receptor Dimerization." This patent outlines methods for identifying inhibitors of dimerization of tyrosine receptor kinases, such as EGFR. The innovative methods involve using a digital computer to create a molecular model of the extracellular dimerization domains of a receptor tyrosine kinase (RTK). By docking chemical databases to this model and scoring the compounds, Yang's methods allow for the identification of high-scoring compounds. Furthermore, the patent details the testing of these compounds for RTK inhibitory activity in vitro and their specificity as RTK inhibitors. Notably, two compounds, NSC11241 and NSC56452, have been disclosed for their ability to inhibit EGF receptor kinase activation in a dose-dependent manner.

Career Highlights

Robert Yang is affiliated with Washington University, where he continues to contribute to research and innovation in his field. His work has garnered attention for its potential applications in therapeutic treatments, particularly in oncology.

Collaborations

Yang has collaborated with esteemed colleagues, including Garland R. Marshall and Linda J. Pike, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Robert Yang's innovative work in identifying inhibitors of tyrosine kinase receptor dimerization represents a significant advancement in biotechnology. His contributions have the potential to influence future treatments for cancer and improve patient outcomes.